Gain Therapeutics annual operating margin
2020
2021
2022
2023
Gain Therapeutics Operating Margin Growth & History (GANX)
Gain Therapeutics's operating margin was −40,328.26% for fiscal 2023.
View full Gain Therapeutics company overviewGain Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | −40,328.26% | −26925.78 pp |
| 2022 | 2022-12-31 | −13,402.48% | −3078.89 pp |
| 2021 | 2021-12-31 | −10,323.59% | +1723.95 pp |
| 2020 | 2020-12-31 | −12,047.54% | — |
Gain Therapeutics quarterly operating margin
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q1.23
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q1 2023 | 2023-03-31 | −9,477.68% | +849.54 pp |
| Q3 2022 | 2022-09-30 | −4,995.67% | +24031.47 pp |
| Q2 2022 | 2022-06-30 | −5,442.98% | −1136.82 pp |
| Q1 2022 | 2022-03-31 | −8,760.39% | +38059.02 pp |
| Q4 2021 | 2021-12-31 | −10,327.22% | +7351.25 pp |
| Q3 2021 | 2021-09-30 | −29,027.14% | −16794.63 pp |
| Q2 2021 | 2021-06-30 | −4,306.17% | +4048.85 pp |
| Q1 2021 | 2021-03-31 | −46,819.42% | −39142.81 pp |
| Q4 2020 | 2020-12-31 | −17,678.47% | — |
| Q3 2020 | 2020-09-30 | −12,232.51% | — |
| Q2 2020 | 2020-06-30 | −8,355.01% | — |
| Q1 2020 | 2020-03-31 | −7,676.61% | — |
Gain Therapeutics operating margin trends
Across the available reported history, Gain Therapeutics's operating margin decreased from −13,402.48% to −40,328.26%, a change of −26925.78 percentage points. The latest reported quarter, Q1 2023, shows −9,477.68%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Gain Therapeutics filings at SEC.gov ↗